BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6594437)

  • 1. A case of chronic myelogenous leukemia following I131 therapy for metastatic thyroid carcinoma.
    Torng JK; Chen YC; Liu CH; Chen FW
    Taiwan Yi Xue Hui Za Zhi; 1984 Jul; 83(7):730-5. PubMed ID: 6594437
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute leukemias after treatment with radioiodine for thyroid cancer.
    Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
    Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloid leukaemia following radioiodine therapy for carcinoma thyroid.
    Bundi RS; Scott JS; Halnan KE
    Br J Radiol; 1977 Jan; 50(589):61-4. PubMed ID: 264404
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine.
    Pavithran K; Doval DC
    Am J Clin Oncol; 2005 Apr; 28(2):216. PubMed ID: 15803020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma.
    Chen L; Shen Y; Luo Q; Yu Y; Lu H; Zhu R
    Thyroid; 2010 Mar; 20(3):337-40. PubMed ID: 20187786
    [No Abstract]   [Full Text] [Related]  

  • 6. [Promising radioiodine therapy of pulmonary metastases of a papillary carcinoma of the thyroid in a 12-year-old boy].
    Blattmann H; Beck A; Moser E
    Radiologe; 1992 Feb; 32(2):68-72. PubMed ID: 1565783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioiodide therapy in pulmonary metastasis of differentiated thyroid cancer--factors affecting the success of I-131 therapy].
    Takada Y; Ohta Y; Kawasaki S; Maki M; Hiroe M; Kusakabe K; Shigeta A; Yamazaki T; Fujimoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jul; 47(7):962-70. PubMed ID: 3658666
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of lung carcinoma induced by radioactive iodine given for disseminated thyroid carcinoma.
    Laing RW; Saunders MI
    Clin Oncol (R Coll Radiol); 1992 Nov; 4(6):394-5. PubMed ID: 1463693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia after iodine-131 treatment for thyroid disorders.
    Laurenti L; Salutari P; Sica S; Piccirillo N; Zini G; Zollino M; Leone G
    Ann Hematol; 1998 Jun; 76(6):271-2. PubMed ID: 9692815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.
    Yoosufani Z; Slavin JD; Hellman RM; Sethi SS; Spencer RP
    J Nucl Med; 1987 Aug; 28(8):1348-50. PubMed ID: 3612295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadal damage due to radioactive iodine (I131) treatment for thyroid carcinoma.
    Ahmed SR; Shalet SM
    Postgrad Med J; 1985 Apr; 61(714):361-2. PubMed ID: 4022871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelogenous leukemia after treatment with 131I for thyroid carcinoma. Report of a case and review of the literature.
    Walgraeve D; Verhoef G; Stul M; Cassiman JJ; Mecucci C; Van den Berghe H; Boogaerts M
    Cancer Genet Cytogenet; 1991 Sep; 55(2):217-24. PubMed ID: 1933823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myeloid leukemia following radioiodine treatment for papillary carcinoma of thyroid.
    Gupta G; Aggarwal M; Juneja R; Seth T
    Indian J Cancer; 2022; 59(3):436-437. PubMed ID: 36412321
    [No Abstract]   [Full Text] [Related]  

  • 14. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
    Kienast O; Hofmann M; Ozer S; Dobrozemsky G; Dudczak R; Kurtaran A
    Thyroid; 2003 May; 13(5):509-10. PubMed ID: 12855020
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
    Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
    Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia after 131I treatment of thyroid cancer--comments on the article 'Second cancer following chemotherapy and radiotherapy--an epidemiological perspective' by J. Kaldor.
    Advani SH; Hege UP
    Acta Oncol; 1992; 31(1):65. PubMed ID: 1586507
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of 131I.
    Zhu RS; Yu YL; Lu HK; Luo QY; Chen LB
    Chin Med J (Engl); 2005 Mar; 118(5):425-8. PubMed ID: 15780216
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.
    Shimon I; Kneller A; Olchovsky D
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):651-4. PubMed ID: 8548952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ph+ acute lymphoblastic leukemia after iodine-131 treatment for thyroid cancer.
    Piccirillo N; Sorà F; Laurenti L; Sica S; Chiusolo P; Leone G
    Haematologica; 1999 Nov; 84(11):1050-1. PubMed ID: 10553170
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic Myeloid Leukemia following Exposure to Radioactive Iodine (I131): A Systematic Review.
    Ali Hailan YM; Al-Dubai HN; Yassin MA
    Oncology; 2023; 101(6):362-368. PubMed ID: 37231874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.